pCPA Activity Overview

Status Total Negotiations Summary
Active Negotiations 36 Non-oncology: 22
Oncology: 14
Under Consideration for Negotiation 29 Non-oncology: 15
Oncology: 14
Completed Negotiations 530 With Letter of Intent: 457
Without agreement: 73
Negotiations That Were Not Pursued 89

pCPA Activity in the last four weeks

Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.

Engagement Letters Issued in the last four weeks

Negotiations Completed in the last four weeks with a Letter of Intent

Brand Name Manufacturer Indication Engagement Date Close Date
Rinvoq AbbVie Corporation Psoriatic Arthritis
Rinvoq AbbVie Corporation Rheumatoid Arthritis
pdp-levETIRAcetam Pendopharm, a division of Pharmascience Inc. Epilepsy

Negotiations Completed in the last four weeks without Agreement

Brand Name Manufacturer Indication Engagement Date Close Date
Jorveza AVIR Pharma Inc. eosinophic esophagitis (maintenance)
Jorveza AVIR Pharma Inc. eosinophilic esophagitis (induction)

Negotiations that pCPA Decided Not to Pursue in the last four weeks

Brand Name Manufacturer Indication Close Date
No negotiations that pCPA decided not to pursue in the last four weeks